| Cholesterol Goal Attainment in Hypertensive Patients: The Impact of Metabolic Syndrome Components. | |
| | |
MedLine Citation:
|
PMID: 22313142 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Abstract Background: Hypertension and dyslipidemia are potentially modifiable cardiovascular risk factors. Methods: We studied hypertensive outpatients regarding goal attainment in controlling dyslipidemia, according to individual cardiovascular risk profile, following the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) guidelines. Factors of goal attainment for low-density lipoprotein cholesterol (LDL-C) were determined. Results: Of the 1,202 patients, this study included 886 (73.8% female, 59.9±11.1 years) with available data to determine cardiovascular risk. Overall, 544 (61.4%) had LDL-C within the goal. Individuals with inappropriate LDL-C were older, had higher systolic blood pressure (SBP), and were more likely to have metabolic syndrome, diabetes, and cardiovascular disease (CVD) and were less likely to show a controlled blood pressure. There was a progressive worsening of LDL-C control as the number of components of metabolic syndrome increased. There was also a progressive increase in the percentage of patients with inappropriate LDL-C with the increase in cardiovascular risk. In a logistic regression model including LDL-C inadequacy as a dependent variable, only age, diabetes, and CVD were predictors of inappropriate LDL-C. Moreover, even with correction for demographic and clinical variables, the inappropriate LDL-C was an independent predictor of CVD. Conclusions: The control of dyslipidemia in hypertensive patients is far from ideal and results are even worse in individuals with CVD. |
| | |
Authors:
|
Cassio José de Oliveira Rodrigues; Hercules Ferreira Ribeiro; Artur Beltrame Ribeiro; Maria Teresa Zanella; Marcelo Costa Batista |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-2-7 |
Journal Detail:
|
Title: Metabolic syndrome and related disorders Volume: - ISSN: 1557-8518 ISO Abbreviation: - Publication Date: 2012 Feb |
Date Detail:
|
Created Date: 2012-2-8 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101150318 Medline TA: Metab Syndr Relat Disord Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
1 Nephrology, Federal University of São Paulo , São Paulo, Brazil . |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Evaluation of treatment continuation with alosetron by IBS-D severity criteria.
Next Document: The cost of diagnosing Type?2 diabetes mellitus by clinical opportunistic screening in general pract...